Oscar Lopez, MD, FAAN, discusses the utility and value of biomarker assessments in distinguishing Alzheimer’s disease from other dementia etiologies. He presents the MRI, CSF, and PET biomarker profiles of several dementia etiologies, and he uses the patient case study to demonstrate how these assessments can help to inform a diagnosis of Alzheimer’s disease in cases with mixed pathologies. Furthermore, Dr. Lopez and the panel discuss recent advancements in plasma biomarkers and the prospect for the implementation of these tools in clinical practice.
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.